Bangalore, India
Kemwell is partnering with Boehringer Ingelheim to construct a biopharmaceutical manufacturing plant in Bangalore, India. Ground was broken on the 15,000-sm greenfield facility in December of 2010. The cGMP plant will support process development, fermentation, purification, and formulation of biologics for early-phase preclinical and clinical studies. The project includes a fill and finish facility and suites for microbial fermentation and the production of protein therapeutics from mammalian cell cultures.
